American Bio Medica Corporation

$0.00+0.00%(+$0.00)
TickerSpark Score
38/100
Weak
87
Valuation
45
Profitability
10
Growth
20
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABMC research report →

52-Week Range0% of range
Low $0.00
Current $0.00
High $0.00

Companywww.abmc.com

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat.

CEO
Jean Neff
IPO
1997
Employees
16
HQ
Kinderhook, NY, US

Price Chart

-50.00% · this period
$0.00$0.00$0.00Jan 22Dec 30Jul 02

Valuation

Market Cap
$4.81K
P/E
-0.00
P/S
0.01
P/B
-0.00
EV/EBITDA
-1.90
Div Yield
0.00%

Profitability

Gross Margin
-21.14%
Op Margin
-136.04%
Net Margin
-154.44%
ROE
85.90%
ROIC
1254.55%

Growth & Income

Revenue
$913.00K · -58.84%
Net Income
$-1,410,000 · -204.54%
EPS
$-0.03 · -172.22%
Op Income
$-1,242,000
FCF YoY
-14.12%

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-0.12
Avg Volume
746

Get TickerSpark's AI analysis on ABMC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Nov 18, 21Sternberg Stuartother0
Oct 19, 21Sternberg Stuartother0
Jul 15, 21MORONEY JOHN Jsell495,500
Jul 1, 20Davis Chaimother35,461
Jul 1, 20Neff Jeanother35,461
Jul 1, 20Jerome Peterother35,461
Dec 31, 19MORONEY JOHN Jother0
Apr 8, 20Davis Chaimother7,751
Apr 8, 20Jerome Peterother7,751
Apr 8, 20Neff Jeanother7,751

Our ABMC Coverage

We haven't published any research on ABMC yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate ABMC Report →

Similar Companies